Eyal Attar
Chief Medical Officer Halda Therapeutics, LLC
Seminars
Tuesday 28th October 2025
Leveraging RIPTACs to Induce Selective Proximity Between Essential & Targeted Proteins for Enhanced Anti-Cancer Activity & Therapeutic Precision
2:00 pm
Tuesday 28th October 2025
CXO Think Tank: How Can TPD Differentiate Itself in a Maturing Market of Targeted Drugs & Enter the Standard of Care to Deliver Transformative Therapies to Oncology Patients & Beyond
8:30 am
